| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 183.730 | 210.749 | 216.380 | 223.771 | 214.201 | 187.725 | 172.563 | 177.612 | 204.671 | 213.031 |
| Total Income - EUR | 183.732 | 213.282 | 217.064 | 223.784 | 214.204 | 188.160 | 172.564 | 179.815 | 213.407 | 221.483 |
| Total Expenses - EUR | 170.841 | 192.856 | 191.858 | 192.444 | 190.111 | 169.761 | 158.229 | 163.311 | 192.952 | 202.573 |
| Gross Profit/Loss - EUR | 12.891 | 20.426 | 25.206 | 31.340 | 24.093 | 18.399 | 14.335 | 16.503 | 20.455 | 18.911 |
| Net Profit/Loss - EUR | 10.719 | 16.920 | 22.884 | 29.081 | 22.029 | 16.988 | 12.851 | 14.966 | 18.319 | 15.885 |
| Employees | 2 | 3 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Tiliae Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 69.133 | 60.584 | 57.930 | 55.267 | 52.628 | 50.610 | 47.693 | 63.847 | 57.728 | 53.026 |
| Current Assets | 39.817 | 36.068 | 46.334 | 50.453 | 45.635 | 53.600 | 57.255 | 49.259 | 60.335 | 63.521 |
| Inventories | 27.669 | 29.081 | 30.417 | 30.977 | 32.240 | 31.815 | 31.940 | 34.143 | 44.303 | 43.696 |
| Receivables | 11.011 | 778 | 14.840 | 17.586 | 12.445 | 14.788 | 11.824 | 13.548 | 12.586 | 9.700 |
| Cash | 1.137 | 6.209 | 1.077 | 1.890 | 950 | 6.998 | 13.491 | 1.567 | 3.446 | 10.124 |
| Shareholders Funds | 63.220 | 68.886 | 73.971 | 79.230 | 71.206 | 65.233 | 60.026 | 62.288 | 80.417 | 62.800 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 45.730 | 27.767 | 30.293 | 26.490 | 27.056 | 38.977 | 44.922 | 48.689 | 36.054 | 52.692 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.129 | 1.592 | 1.055 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Tiliae Pharma S.r.l.